BioFreedom proven in LEADERS FREE for Ultra-short DAPT
August 31, 2018 | News | BioFreedom
Freedom to treat with 1 month DAPT - Proven for ultra-short DAPT in the LEADERS FREE study, BioFreedom was more safe and effective than a BMS in high bleeding risk patients
HIGH BLEEDING RISK PATIENTS
January 20,2010 | News | BioFreedom
BioFreedom is the only active stent with CE mark for
ultra-short 1 month DAPT, in High bleeding Risk (HBR)
patients, supported by clinical data from a double-blind
randomized controlled trial.
CARDIAC DEATH IN ACS?
March 20, 2019 | News | BioMatrix+BioFreedom
Can you find any other stent ?...
…that significantly reduces Cardiac Death vs. another DES in STEMI?
…that significantly reduces Cardiac Death vs. BMS in HBR ACS patients?